AngioDynamics financials
$15.60+0.39%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 May 31 | FY25 May 31 | FY24 May 31 | FY23 May 31 | FY22 May 31 | FY21 May 31 | FY20 May 31 | FY19 May 31 | FY18 May 31 | FY17 May 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $320.2M | $292.5M | $303.9M | $338.8M | $316.2M | $291.0M | $264.2M | $270.6M | $261.7M | $269.8M |
| Gross profit | $174.9M | $157.7M | $154.7M | $174.2M | $165.7M | $156.8M | $150.3M | $156.0M | $143.9M | $143.9M |
| Gross margin | 54.6% | 53.9% | 50.9% | 51.4% | 52.4% | 53.9% | 56.9% | 57.6% | 55.0% | 53.4% |
| Operating income | -$39.9M | -$39.7M | -$246.5M | -$51.2M | -$28.5M | -$35.3M | -$167.1M | -$9.4M | -$14.2M | -$11.2M |
| Net income | -$36.7M | -$34.0M | -$184.3M | -$52.4M | -$26.5M | -$31.5M | -$166.8M | $61.3M | $16.3M | $5.0M |
| Net margin | −11.5% | −11.6% | −60.7% | −15.5% | −8.4% | −10.8% | −63.1% | 22.7% | 6.2% | 1.9% |
| Diluted EPS | $-0.88 | $-0.83 | $-4.59 | $-1.33 | $-0.68 | $-0.82 | $-4.39 | $1.64 | $0.44 | $0.14 |
| EBITDA | -$17.0M | -$13.9M | -$59.3M | -$5.8M | $9.9M | $11.0M | $9.8M | $24.8M | $24.7M | $25.9M |
| Operating cash flow | $3.1M | -$10.1M | -$28.2M | $78.0K | -$7.2M | $15.6M | -$14.6M | $37.4M | $41.3M | $55.7M |
| Free cash flow | $508.0K | -$14.6M | -$30.7M | -$3.7M | -$22.9M | $10.4M | -$21.8M | $34.3M | $38.9M | $52.7M |
| Diluted shares | 41.5M | 40.9M | 40.2M | 39.5M | 39.0M | 38.3M | 38.0M | 37.5M | 37.1M | 36.6M |
Balance sheet
| Period end | May 31 | May 31 | May 31 | May 31 | May 31 | May 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $53.9M | $55.9M | $76.1M | $44.6M | $28.8M | $48.2M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $0.00 | $0.00 | $0.00 | $49.8M | $25.0M | $20.0M |
| Total assets | $267.2M | $280.1M | $317.7M | $532.6M | $552.8M | $561.4M |
| Total liabilities | $96.3M | $97.2M | $112.1M | $154.3M | $128.3M | $122.0M |
| Shareholders' equity | $170.8M | $183.0M | $205.6M | $378.3M | $424.5M | $439.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology